Rapport Therapeutics, Inc. Common Stock (RAPP) Insider Trading
- $1,320,014.64
- $1,512,927.20
- Sept. 17, 2025
- Wendy B Young
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Sept. 17, 2025 | CEO | 40,835 | $26.32 | Sell | $1,074,777.20 | |
| Sept. 11, 2025 | Director | 3,500 | $22.60 | Buy | $79,100.00 | |
| Sept. 8, 2025 | COO | 5,000 | $38.33 | Sell | $191,650.00 | |
| Aug. 15, 2025 | Insider | 8,500 | $15.00 | Sell | $127,500.00 | |
| July 15, 2025 | Insider | 8,500 | $14.00 | Sell | $119,000.00 | |
| March 12, 2025 | Director | 6,000 | $10.21 | Buy | $61,260.00 | |
| March 12, 2025 | CFO | 9,900 | $10.10 | Buy | $99,990.00 | |
| July 1, 2024 | Director | 44,032 | $24.52 | Buy | $1,079,664.64 |
Insiders are both buying and selling Rapport Therapeutics, Inc. Common Stock stock.
The insider traders at Rapport Therapeutics, Inc. Common Stock are: David Bredt, Wendy B Young, Abraham Ceesay, Cheryl Gault, James Healy, and Troy A Ignelzi
The most active insider trader at Rapport Therapeutics, Inc. Common Stock is David Bredt with 2 trades.
Abraham Ceesay has sold the most Rapport Therapeutics, Inc. Common Stock stock with a total value of $2,149,554.40.
James Healy has bought the most Rapport Therapeutics, Inc. Common Stock stock with a total value of $2,159,329.28.
The most recent insider trade for Rapport Therapeutics, Inc. Common Stock was on Sept. 17, 2025.
The single biggest insider buy for Rapport Therapeutics, Inc. Common Stock was from James Healy with a total value of $1,079,664.64 on July 1, 2024.
The single biggest insider sell for Rapport Therapeutics, Inc. Common Stock was from Abraham Ceesay with a total value of $1,074,777.20 on Sept. 17, 2025.